Barry Gorlitsky, MD
Nephrology · Greenville, SCNPI 1881823276
Payments from drug & device makers
Across 596 payments — averaging $5178.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$1.7M
- Vertex$720K
- Amgen$190K
- AstraZeneca$185K
- Boehringer Ingelheim International GmbH$117K
- Beigene, Ltd.$99K
- plus $81K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 110 | $1,695,632 |
| Vertex | 8 | $719,678 |
| Amgen(2 entities) | 322 | $189,830 |
| AstraZeneca | 49 | $184,870 |
| Boehringer Ingelheim International GmbH | 3 | $116,681 |
| Beigene, Ltd. | 4 | $98,556 |
| Beigene USA, Inc. | 18 | $41,913 |
| Astrazeneca UK Limited | 2 | $18,356 |
| Beone Medicines USA, Inc. | 7 | $16,735 |
| Abbott | 2 | $2,125 |
| Johnson & Johnson | 1 | $375 |
| Mozarc Medical US LLC | 6 | $351 |
| GSK | 6 | $207 |
| Mallinckrodt Enterprises LLC | 9 | $205 |
| Akebia Therapeutics Inc | 8 | $164 |
| Otsuka America Pharmaceutical, Inc. | 11 | $139 |
| Baxter Healthcare | 3 | $133 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $128 |
| Vifor Pharma, Inc. | 6 | $96 |
| Mallinckrodt Hospital Products Inc. | 2 | $89 |
| Travere Therapeutics, Inc. | 3 | $78 |
| Medtronic | 1 | $53 |
| OPKO Pharmaceuticals, LLC | 2 | $47 |
| Fresenius USA Marketing, Inc. | 1 | $40 |
| Bayer | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
| Novo Nordisk | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Scpharmaceuticals Inc. | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $15 |
How this compares
$3,086,640 in reported general payments places this provider in the 95th percentile of 180 nephrology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Greenville
- Blake ShustermanGreenville$66K
- Marcus MoremanGreenville$26K
- Joachim HertelGreenville$16K
- Tarak ShahGreenville$9K
- Istvan BognarGreenville$6K
- William WardGreenville$5K
- Carlos ZayasGreenville$5K
- Hari Naga GarapatiGreenville$5K
- Kaye ChristopherGreenville$5K
- Willy TsaiGreenville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.